CareDx, Inc., headquartered in Brisbane, California, is a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant recipients. CareDx offers products across the transplant testing continuum, including AlloMapÂŽ and AlloSureÂŽ for post-transplant surveillance and QTYPEÂŽ, TruSightÂŽ HLA, Olerup SSPÂŽ and Olerup SBTÂŽ for pre-transplant HLA testing.
Source
